Highlights Tianjin Development Holdings Limited

Equities

882 HK0882007260

Delayed Hong Kong S.E. Other stock markets 12:55:42 26/06/2024 pm IST			5-day change	1st Jan Change
1.81 ^HKD	+1.12%		-3.72%	+23.13%

11/06	Lisheng Pharmaceutical Avails of 92-Day Structured Deposit Product	MT
27/03	Tianjin Development’s Chairman Steps Down; Successor Named	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Tianjin Development Holdings Limited Approves Final Dividend	13/06	CI
Lisheng Pharmaceutical Avails of 92-Day Structured Deposit Product	11/06	MT
Tianjin Development Posts 77% Profit Jump for 2023	26/04	MT
Tianjin Development Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 29 July 2024	27/03	CI
Tianjin Development Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	27/03	CI
Tianjin Lisheng Pharmaceutical's 2023 Profit Surges on Gains from Asset Disposals; Shares Jump 4%	22/03	MT
Tianjin Development Holdings Expects Up to 80% Jump in 2023 Profit	14/03	MT
Tianjin Development Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	13/03	CI
Lisheng Pharmaceutical Buys 65% Stake in Qingchun Kangyuan Pharmaceutical for 137 Million Yuan; Shares Up 3%	02/01	MT
Tianjin Arm Lisheng Pharmaceutical To Buy Chinese Medicine Firm Jiangxi Qingchun Kangyuan	14/12	MT
Tianjin Lisheng Pharma Setting Up Venture Capital Fund	12/12	MT
Tianjin Development to Vote Dec. 5 on Lisheng Pharma's Sale of Tianjin Pharmaceutical Finance Stake	10/11	MT
Tianjin Development Holdings' H1 Attributable Profit Grows	30/23/30	MT
Tianjin Development Holdings Limited Declares Interim Dividend for the Six Months Ended 30 June 2023, Payable on 30 October 2023	30/23/30	CI
Tianjin Development Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	30/23/30	CI
Lisheng Pharmaceutical's H1 Attributable Profit Jumps	25/23/25	MT
Lisheng Pharmaceutical Eyes 247.9 Million Yuan from Potential Land Resumption Deal	26/23/26	MT
Tianjin Development Holdings Limited Approves Final Dividend	21/23/21	CI
Tianjin Lisheng Pharmaceutical's Q1 Attributable Profit Increases	27/23/27	MT
Tianjin Development Logs 24% Drop in 2022 Profit	31/23/31	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Tianjin Development Holdings Limited

Equities

882

HK0882007260

Highlights

Filters